DYAI

Dyadic International, Inc.

1.61 USD
-0.34 (-17.44%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Dyadic International, Inc. stock is up 15.83% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 52.63% of the previous 19 May’s closed higher than April.

About Dyadic International, Inc.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. It offers DYAI-100, SARS-CoV-2-S-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates.